Autonomix Medical, Inc. - התחייבויות לטווח ארוך של החברה AMIX

Autonomix Medical, Inc. (AMIX) develops intelligent AI-powered catheter systems for the automated control of nerve impulses during surgery. The company holds a proprietary tissue mapping method that ensures steady demand for both equipment and consumables. The daily price action shown below is supported by a strong team of neuroengineers, with the indicator standing at 0.00, while business growth relies on expanding the staff of regional sales representatives.

For Autonomix Medical, Inc., which develops high-precision neuromodulation systems, this indicator captures the total amount of liabilities with a maturity exceeding one year. The metric measures long-term credit load, allowing for the differentiation of liquidity deficits from targeted expansion financing. Daily monitoring of the corporation's long-term loans and borrowings reveals current trends in the liability structure. The current value is 0.00. An increase in this figure confirms investments in innovations for the treatment of neurological disorders.